Related Experiment Videos
[Management of dyslipidemia in diabetic CKD patients]
Ziad A Massy1, Michel Andréjak
1Service de pharmacologie clinique, CHU Amiens sud, et INSERM ERI-12, UPJV, Amiens, France. massy@u-picardie.fr
Abstract:
Diabetic nephropathy is a frequent complication in type 2 diabetic. Patients with diabetic nephropathy have a characteristic dyslipidemia profile associated increased concentrations of triglycerides, reduced levels of HDL cholesterol, and qualitative abnormalities of LDL. The dyslipidemia management in patients with diabetic nephropathy not yet in dialysis includes diet, insulin sensitizers (glitazones, metformin?), and hypolipemic agents, with statins as a first choice.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management